Clinical trials
Completed Phase 2 Renal Insufficiency trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 5 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 8 |
| 2009 | 1 |
| 2010 | 10 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 1 |
| 2014 | 6 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 65 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Akebia Therapeutics | 4 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 3 |
| Novartis Pharmaceuticals | 3 |
| Veloxis Pharmaceuticals | 3 |
| GlaxoSmithKline | 2 |
| Hamilton Health Sciences Corporation | 2 |
| NovaCardia, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2 |
| Takeda | 2 |
| University Health Network, Toronto | 2 |
| Amgen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Renal Insufficiency | 65 |
| Renal Insufficiency, Chronic | 11 |
| Kidney Diseases | 9 |
| Multiple Myeloma | 9 |
| Anemia | 8 |
| Kidney Failure, Chronic | 8 |
| Heart Failure | 5 |
| Diabetes Mellitus, Type 2 | 3 |
| Fibrosis | 3 |
| Acute Kidney Injury | 2 |
Trials
Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.